of the bladder that is high-grade, whether it is primary or recurrent. This high-risk group includes patients with high-grade papillary stage Ta or T1 tumors and any patient with carcinoma in situ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback